Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shohreh Farhadi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scientific Reports|March 28, 2026
7SK-enriched exosomes suppress the cancer phenotypes in human lung cancer cells: insights from 2D and microfluidic 3D in vitro modelsShahin Aghamiri, Mohammad Ajoudanian, Shohreh Farhadi, et al.
Current Pharmaceutical Biotechnology|January 29, 2020
Monocyclic Peptides: Types, Synthesis and ApplicationsYalda Khazaei-Poul, Shohreh Farhadi, Sepideh Ghani, et al.
Life Sciences|April 3, 2023
Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cellsShohreh Farhadi, Samira Mohammadi-Yeganeh, Jafar Kiani, et al.
Journal of Immunotoxicology|July 15, 2016
Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosisGhasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Mousa Mohammadnia-Afrouzi, et al.
Scientific Reports|September 22, 2022
RNAa-mediated epigenetic attenuation of the cell senescence via locus specific induction of endogenous SIRT1Neda Mokhberian, Kazem Sharifi, Ehsan Soleymaninejadian, et al.
Current Molecular Medicine|August 18, 2023
Physicochemical Stimulus-Responsive Systems Targeted with Antibody DerivativesRezvan Mohammadi, Sepideh Ghani, Roghaye Arezumand, et al.
Biotechnology and Bioengineering|June 25, 2021
Nonviral siRNA delivery systems for pancreatic cancer therapyShahin Aghamiri, Pourya Raee, Sam Talaei, et al.
International Immunopharmacology|April 4, 2020
Nanomedicine for improvement of dendritic cell-based cancer immunotherapyVida Hashemi, Shohreh Farhadi, Mitra Ghasemi Chaleshtari, et al.
International Journal of Pharmaceutics|April 3, 2020
Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progressionAfshin Nikkhoo, Narges Rostami, Shohreh Farhadi, et al.
Journal of Cellular Physiology|May 20, 2020
Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cellsNarges Rostami, Afshin Nikkhoo, Yalda Khazaei-Poul, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scientific Reports|March 28, 2026
7SK-enriched exosomes suppress the cancer phenotypes in human lung cancer cells: insights from 2D and microfluidic 3D in vitro modelsShahin Aghamiri, Mohammad Ajoudanian, Shohreh Farhadi, et al.
Current Pharmaceutical Biotechnology|January 29, 2020
Monocyclic Peptides: Types, Synthesis and ApplicationsYalda Khazaei-Poul, Shohreh Farhadi, Sepideh Ghani, et al.
Life Sciences|April 3, 2023
Exosomal delivery of 7SK long non-coding RNA suppresses viability, proliferation, aggressiveness and tumorigenicity in triple negative breast cancer cellsShohreh Farhadi, Samira Mohammadi-Yeganeh, Jafar Kiani, et al.
Journal of Immunotoxicology|July 15, 2016
Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosisGhasem Ghalamfarsa, Mohammad Hojjat-Farsangi, Mousa Mohammadnia-Afrouzi, et al.
Scientific Reports|September 22, 2022
RNAa-mediated epigenetic attenuation of the cell senescence via locus specific induction of endogenous SIRT1Neda Mokhberian, Kazem Sharifi, Ehsan Soleymaninejadian, et al.
Current Molecular Medicine|August 18, 2023
Physicochemical Stimulus-Responsive Systems Targeted with Antibody DerivativesRezvan Mohammadi, Sepideh Ghani, Roghaye Arezumand, et al.
Biotechnology and Bioengineering|June 25, 2021
Nonviral siRNA delivery systems for pancreatic cancer therapyShahin Aghamiri, Pourya Raee, Sam Talaei, et al.
International Immunopharmacology|April 4, 2020
Nanomedicine for improvement of dendritic cell-based cancer immunotherapyVida Hashemi, Shohreh Farhadi, Mitra Ghasemi Chaleshtari, et al.
International Journal of Pharmaceutics|April 3, 2020
Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progressionAfshin Nikkhoo, Narges Rostami, Shohreh Farhadi, et al.
Journal of Cellular Physiology|May 20, 2020
Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cellsNarges Rostami, Afshin Nikkhoo, Yalda Khazaei-Poul, et al.
Pageof 2